Criteria of obesity for Asian population. Literature review
https://doi.org/10.29413/ABS.2018-3.3.15
Abstract
Scientific Centre for Family Health and Human Reproduction Problems (ul. Timiryazeva 16, Irkutsk 664003, Russian Federation) Problems of pathogenesis, diagnosis, and treatment of obesity are actively discussed. The annual increase in the incidence requires improved approaches to prevention, diagnosis, and drug-free treatment of this pathological condition. Modern estimates of obesity ignore modern concepts of the heterogeneity of the disease, the role of visceral fat depots, metabolic phenotypes, and the individual cardiometabolic risk in a patient is not fully assessed. The prevalence of obesity is increasing among Asian adults due to rapid economic development and lifestyle. Obesity significantly elevates the risk of CVD (cardiovascular disease), diabetes, insulin resistance and other metabolic disorders. BMI is a widely used anthropometric index for measuring body fatness in clinical practice and epidemiological studies; Asian people are more likely to have a higher percentage of body fat at lower BMI and WC than Europeans, a number of researches were to determine the associations of BM1, waist circumference (WC) and waist-height ratio (WHtR) with CVD risk factors and to evaluate the optimal cut-offvalues to define overweight or obesity in Asian adults. In this review the major pathological factors connected to obesity are generalized. It has not been established which specific measures of obesity might be most appropriate for predicting CVD risk in Asians.
About the Author
L. V. Belenkaya
Scientific Centre for Family Health and Human Reproduction Problems
Russian Federation
Russian Federation
References
1. Бальжиева В.В., Баирова Т.А., Рычкова Л.В., Аюрова Ж.Г., Колесников С.И. Этногенетические аспекты ожирения у детей и подростков // Вопросы детской диетологии. - 2017. - Т. 15, № 5. - С. 29-34
2. Колесникова Л.И., Семенова Н.В., Жамбалова Р.М., Мадаева И.М. Процессы липопероксидации и система антиоксидантной защиты у женщин с нарушениями сна в перименопаузе: этнический аспект // Клиническая лабораторная диагностика. - 2017. -Т. 62, № 2. - С. 77-82
3. Курашова Н.А., Гребенкина Л.А., Долгих М.И., Натяганова Л.В., Дашиев Б.Г Этнические особенности некоторых показателей метаболического и клинического статуса инфертильных мужчин // Acta Biomedica Scientifica. - 2017. - Т. 2, № 5, Ч. 1. - С. 38-42
4. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., James W.P., Loria C.M., Smith S.C. Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. (2009). Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120 (16), 1640-1645. DOI: 10.1161/ CIRCULATIONAHA.109.192644.
5. American Diabetes Association. (2008). Economic costs of diabetes in the U.S. in 2007. Diabetes Care, 31 (3), 596-615. DOI: 10.2337/dc08-9017.
6. Azziz R., Carmina E., Chen Z., Dunaif A., Laven J.S., Legro R.S., Lizneva D., Natterson-Horowtiz B., Teede H.J., Yildiz B.O. (2016). Polycystic ovary syndrome. Nat Rev Dis Primers, 2, 16057. DOI: 10.1038/nrdp.2016.57
7. Balkau B., Charles M.A. (1999). Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabet Med, 16 (5), 442-443.
8. Deurenberg-Yap M., Chew S.K., Lin V.F., Tan B.Y., van Staveren W.A., Deurenberg P. (2001). Relationships between indices of obesity and its co-morbidities in multi-ethnic Singapore. Int J Obes Relat Metab Disord, 25 (10), 1554-1562.
9. Examination Committee of Criteria for "Obesity Disease" in Japan; Japan Society for the Study of Obesity. (2002). New criteria for "obesity disease" in Japan. Circ J., 66 (11), 987-992.
10. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (2001). Executive summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 285 (19), 2486-2497.
11. Ford E.S., Giles W.H., Dietz WH. (2002). Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey, JAMA, 287 (3), 356-359.
12. Huxley R., Mendis S., Zheleznyakov E., Reddy S., Chan J. (2010). Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk--a review of the literature. Eur J Clin Nutr, 64(1), 16-22. doi: 10.1038/ejcn.2009.68.
13. International Diabetes Federation. (2013). IDF Diabetes Atlas, 6th edition. Brussels, Belgium: International Diabetes Federation. Available from: URL: http://www.idf.org/diabetesatlas
14. Jalba M.S., Rhoads G.G., Demissie K. (2008). Association of codon 16 and codon 27 beta 2-adrenergic receptor gene polymorphisms with obesity: a meta-analysis. Obesity (Silver Spring), 16 (9), 2096-2106.
15. Klein S., Allison D.B., Heymsfield S.B., Kelley D.E., Leibel R.L., Nonas C., Kahn R; Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; American Society for Nutrition; American Diabetes Association. (2007). Waist circumference and cardiometabolic risk: a consensus statement from shaping America’s health: Association for Weight Management and Obesity Prevention; NAASO, the Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr, 85 (5), 1197-1202.
16. Manolopoulos K.N., Karpe F., Frayn K.N. (2010). Gluteofemoral body fat as a determinant of metabolic health. Int J Obes (Lond), 34 (6), 949-959. DOI: 10.1038/ ijo.2009.286
17. McKeigue P.M., Shah B., Marmot M.G. (2004). Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet, 337 (8738), 382-386.
18. Park H.S., Oh S.W., Cho S.I., Choi W.H., Kim Y.S. (2004). The metabolic syndrome and associated lifestyle factors among South Korean adults. Int J Epidemiol, 33 (2), 328336.
19. Suturina L.V., Atalyan A.V., Darzhaev Z.Y., Belenkaya L.V., Baldano M.N., Lazareva L.M. (2017). Overweight and Obesity Prevalence in Referral Population of Infertile Women with Polycystic Ovary Syndrome. Adv Obes Weight Manag Control, 7 (1), 00188. DOI: 10.15406/aowmc.2017.07.00188
20. WHO. (2006). Factsheet N 311. Obesity and overweight.
21. World Health Organization. (2008). World Health Statistics. Available at: http://www.who.int/whosis/whostat/2008/en/.
22. World Health Organization. Regional Office for the Western Pacific. (2000). The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications Australia. Available at: http://www.who.int/iris/handle/10665/206936.
23. Zimmet P., Magliano D., Matsuzawa Y., Alberti G., Shaw J. (2005). The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb, 12 (6), 295-300.
Review
For citations:
Belenkaya L.V. Criteria of obesity for Asian population. Literature review. Acta Biomedica Scientifica. 2018;3(3):99-102. (In Russ.) https://doi.org/10.29413/ABS.2018-3.3.15
Views:
1399
.png)
Email this article 
